Business · 16/02/2001
FDA Releases Guidance for Industry on Intermediates in Drug Substance Synthesis
The FDA has made available a guidance document for industry that provides recommendations for companies changing the manufacturing process of intermediates in drug substance synthesis during the postapproval period.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →